Study's Care of Acute Pancreatitis at Saint-Etienne University Hospital.

September 13, 2024 updated by: Centre Hospitalier Universitaire de Saint Etienne

Internal medicine units treat patients with undifferentiated or multisystem diseases, with a non-specific organ approach.

In some cases, patients with single-organ disease may be admitted to internal medicine wards. Acute pancreatitis is the most common gastrointestinal illness requiring acute admission to hospital. It is characterised by local and systemic inflammation of the pancreas corresponding to single-organ disease.

For patients with single-organ disease such as acute pancreatitis, it is not known whether admission to internal medicine is as effective as admission to a unit specialising in a specific organ, such as hepato-gastro-enterology.

Study Overview

Status

Recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Estimated)

140

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Study Contact Backup

Study Locations

  • France
      • Saint-Etienne, France, 42055
        • Recruiting
        • CHU de Saint-Etienne
        • Contact:
        • Principal Investigator:
          • Kyria REGALADE, resident
        • Sub-Investigator:
          • Baptiste GRAMONT, MD
        • Sub-Investigator:
          • Julie GOUTTE, MD

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

All adult patients hospitalized from January 1, 2022, to December 31, 2023 in the University Hospital of Saint Etienne with a primary diagnosis of acute pancreatitis in Internal Medicine and gastroenterology will be included.

Description

Inclusion Criteria:

  • adult patient
  • primary diagnosis of acute pancreatitis in Internal Medicine and gastroenterology.

Exclusion Criteria:

-

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
The Internal Medicine Unit arm
It includes all patients hospitalized in the Internal Medicine Unit. Patients may have been previously hospitalized in the emergency department or in another department such as intensive care.
Other: Data collection
Data collected: Socio-demographic, hospital, clinical, biological, and imaging data
The hepato-gastro-enterology Unit arm
It includes all patients hospitalized in the Gastroenterology unit. Patients may have been previously hospitalized in the emergency department or in another department such as intensive care.
Other: Data collection
Data collected: Socio-demographic, hospital, clinical, biological, and imaging data

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Performance Stay Length Index
Time Frame: From the date of inclusion to the date of discharge from hospital, assessed for up to 100 months
"Performance Stay Length Index", is a measure used to evaluate the efficiency of hospital care in terms of patients' length of stay. This index is calculated by comparing the average length of stay of patients in a given service to a predefined reference, often based on established standards or goals.
From the date of inclusion to the date of discharge from hospital, assessed for up to 100 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Rate of complications at 1 year
Time Frame: During one year from diagnosis
Number of complications documented in the computerized medical record, one year from diagnosis.
During one year from diagnosis
Rate of rehospitalization at 1 year
Time Frame: During one year from diagnosis
Number of hospitalizations documented in the computerized medical record, one year from diagnosis.
During one year from diagnosis

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Sponsor

Centre Hospitalier Universitaire de Saint Etienne

Investigators

  • Principal Investigator: Kyria REGALADE, resident, CHU Saint-Etienne

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

June 6, 2024

Primary Completion (Estimated)

April 1, 2025

Study Completion (Estimated)

April 1, 2025

Study Registration Dates

First Submitted

September 10, 2024

First Submitted That Met QC Criteria

September 13, 2024

First Posted (Estimated)

September 19, 2024

Study Record Updates

Last Update Posted (Estimated)

September 19, 2024

Last Update Submitted That Met QC Criteria

September 13, 2024

Last Verified

June 1, 2024

More Information

Terms related to this study

Keywords

Additional Relevant MeSH Terms

Other Study ID Numbers

  • IRBN902024/CHUSTE

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Acute Pancreatitis

Clinical Trials on Data collection

Search Similar Trials

Sponsors and Collaborators

Medical Conditions

Drug Interventions

CROs by country

CROs in Tanzania

Conditions

Rare Diseases

Drug Interventions

Dietary Supplements

Sponsor/Collaborators

Locations

Subscribe